17-37665106-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000615265.1(ENSG00000277688):​n.591-19109T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.213 in 152,212 control chromosomes in the GnomAD database, including 4,203 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 4203 hom., cov: 32)

Consequence

ENSG00000277688
ENST00000615265.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.164

Publications

3 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000615265.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000615265.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000277688
ENST00000613901.1
TSL:4
n.109-10718T>C
intron
N/A
ENSG00000277688
ENST00000615265.1
TSL:3
n.591-19109T>C
intron
N/A
ENSG00000277688
ENST00000717157.1
n.266-270T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.213
AC:
32356
AN:
152094
Hom.:
4185
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.101
Gnomad AMI
AF:
0.121
Gnomad AMR
AF:
0.407
Gnomad ASJ
AF:
0.216
Gnomad EAS
AF:
0.289
Gnomad SAS
AF:
0.193
Gnomad FIN
AF:
0.160
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.241
Gnomad OTH
AF:
0.232
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.213
AC:
32396
AN:
152212
Hom.:
4203
Cov.:
32
AF XY:
0.213
AC XY:
15872
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.101
AC:
4190
AN:
41560
American (AMR)
AF:
0.408
AC:
6232
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
751
AN:
3472
East Asian (EAS)
AF:
0.290
AC:
1500
AN:
5170
South Asian (SAS)
AF:
0.194
AC:
935
AN:
4824
European-Finnish (FIN)
AF:
0.160
AC:
1690
AN:
10594
Middle Eastern (MID)
AF:
0.310
AC:
90
AN:
290
European-Non Finnish (NFE)
AF:
0.241
AC:
16404
AN:
67990
Other (OTH)
AF:
0.233
AC:
494
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1254
2508
3763
5017
6271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.234
Hom.:
555
Bravo
AF:
0.234

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
13
DANN
Benign
0.93
PhyloP100
0.16

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs12449449;
hg19: chr17-36025136;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.